text:
September 17: "Analysis Finds Select Group of Stage IV Lung Cancer Patient Population Achieves Long-Term Survival after Aggressive Treatments" (HealthCanal)
September 17: "Identification of Mutations Causing Lung Cancer Resistance Leads to New Treatment Strategies" (Medical Xpress)
September 16: "Long-Term Results of RTOG 0236 Confirm Good Primary Tumor Control, Positive Five-Year Survival Rates" (Medical Xpress)
September 16: "Chest Radiation plus Chemo Cuts Recurrence in Advanced Lung Cancers" (Monthly Prescribing Reference)
September 15: "Marker Found in One in Six People Could Give Higher Risk of Lung and Other Cancers" (Medical Xpress)
September 15: "New Trial to Test Immunotherapy Vaccine for Lung Cancer" LungCancerNewsToday.com)
September 15: "Novel Theory Slows Cancer Growth" (LaboratoryTalk.com)
September 12: "Merck KGaA Ends Lung Cancer Vaccine Trials" (Reuters UK)
September 11: "Lung Cancer Screening Could Save Thousands, Study Suggests" (News-Medical.net)
September 10: "Scientists Devise Breath Test for Lung Cancer" (BBC/British Broadcasting Corporation)
September 10: "EGFR Mutations in Circulating Tumor DNA (ctDNA) Can Be Used in Place of Tumor Tissue in Non-Small Cell Lung Cancer (NSCLC) Diagnostics" (Oncology Nurse Advisor)
September 8: "Combination MiRNA Therapy Offers Promising Therapeutic Avenue for Non-Small-Cell Lung Cancer" (News-Medical.net)
September 8: "Patients with Lung Cancer Have Higher Breath Temperature" (Oncology Nurse Advisor)
September 5: "Combination MicroRNA Therapy Shown to Suppress Non-Small-Cell Lung Cancer" (Medical Xpress)
September 4: "F.D.A. Allows First Use of a Novel Cancer Drug" (The New York Times)
September 4: "A Minimally Invasive, High-Performance Intervention for Staging Lung Cancer" (HealthCanal)
September 4: "Lung Cancer Study Reveals New Drug Combination Targets" (Chronicle & Sun Newspapers)
September 3: "Study Finds CT Lung Cancer Screening to Be Cost Effective in Saving Lives" (DOTmed)
August 28: "Is Time to First Morning Cigarette a Good Marker of Lung Cancer Risk?" (HCPLive)
August 28: "Mutant Allele Frequency Predicts Lung Cancer TKI Response" (News-Medical.net)
August 27: "Majority of Cancer Patients with Depression Untreated; Integrated Collaborative Care Found 'Strikingly' Effective" (The Oncology Report)
August 27: "Cancer Researchers Use Supercomputer to Gain Insight into New Treatment Technology" (Medical Xpress)
August 26: "Scientists Grow Miniature Lung to Test Cancer Drugs" (The Washington Post)
August 26: "Pfizer to Test Xalkori Lung Cancer Drug with Merck Immunotherapy" (Yahoo! News)
August 25: "Progress Seen in Immunotherapy for Lung Cancer" (Clinical Oncology News)
August 22: "Online Screening for Rare Lung Cancer Subtypes Opens Door to New Kind of Clinical Trial" (Medical Xpress)
August 22: "High Concordance between EGFR Mutations from Circulating-Free Tumor DNA and Tumor Tissue in Non-Small Cell Lung Cancer" (Science Codex)
August 22: "BIM Deletion Predicts Survival in Advanced Non-Small Cell Lung Cancer" (International Association for the Study of Lung Cancer)
August 22: "Novel Oncogenic RET Mutation Found in Small Cell Lung Cancer" (International Association for the Study of Lung Cancer)
August 22: "OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer" (PipelineReview.com)
August 21: "An Unstoppable Killer: New Research Suggests Cancer Can't Be Eradicated" (NPR/National Public Radio)
August 21: "The Stigma of Lung Cancer" (Cancer.net)
August 21: "Research: Anti-Cancer Spice Promotes Lung Cancer" (Digital Journal)
August 19: "Best Methods for ALK Screening in Non–Small-Cell Lung Cancer" (CancerNetwork.com)
August 18: "NIH Announces the Launch of 3 Integrated Precision Medicine Trials" (National Institute of Health)
August 15: "RNA Combination Therapy for Lung Cancer Offers Promise for Personalized Medicine" (Medical Xpress)
August 15: "Common Respiratory Diseases Tied to Lung Cancer Risk" (U.S. News & World Report)
August 13: "Blocking the Signal: Brain-Derived Growth Factor May Lure Lung Cancer Cells to Migrate" (Medical Xpress)
August 11: "Decline
in US Lung Cancer Rates, Varying by Race, Gender, Age" (Medical News Today)
August 8: "Halaven
Fails to Meet Primary Endpoint in NSCLC" (Healio)
August 6:
"Smoking Habits Persisted among Cancer Survivors" (Healio)
August 4: "Scientists
Discover Gene that Prevents Lung Cancer Metastasis" (Oncology Nurse Advisor)
August 4: "Lung Cancer Diagnosis Tool Shown to Be Safe
and Effective for Older Patients" (Medical Xpress)
August 2:
"Next-Generation ALK Inhibitors Effective in Patients With Brain Metastases"
August 1:
"Experimental Drugs Hit KRAS and Downstream Targets in NSCLC" (Onclive)
August 1: "Search
for Curative Therapies Continues in Lung Cancer" (OncLive)
1: "TKIs Combined With Other Drugs May Prove More Effective in NSCLC" (OncLive)
July 31: "CT
Screening for Lung Cancer an Important Life-Saving Tool" (OncLive)
July 31: "Lung
Congress to Offer Thorough Review of Latest Research Findings" (OncLive)
July 31: "Ambitious
Lung-MAP Trial Launched With Five Novel Drugs"
July 29: Cancer
tumors absorb sugar for mobility (ScienceDaily)
July 29: "Penn
Team Makes Cancer Glow to Improve Surgical Outcomes" (Medical Xpress)
July 29: "Drug
Combo Broke through Drug Resistance in Some Patients with Advanced Lung Cancer" (Oncology
July 28: "Cancer
Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation" (MedicalXpress)
July 28: "Potential
'Universal' Blood Test for Cancer Discovered" (Medical Xpress)
July 25: "Frontline
Nivolumab Leads to Early, Durable Responses in NSCLC" (OncLive)
July 23: "Antioxidants May Not Fight
Cancer, According to Research" (Oncology Nurse Advisor)
July 23: Nab-Paclitaxel in Non-Small
Cell Lung Cancer" (OncLive)
July 21: "Ros1 Gene Fusions Found in
2.4% of Asian Patients with Lung Adenocarcinoma, Associated with Young Age at
Diagnosis" (Medical Xpress)
July 21: "Increased Overall Survival for
Advanced Stage NSCLC Patients is Associated with Availability of Less Toxic
Chemotherapy" (International Association for the Study of Lung Cancer)
17: "New Gene Discovered that Stops the Spread of Deadly Cancer"
(Medical Xpress)
July 16: "Emerging
Treatments Offer Hope for Patients with Deadly Small Cell Lung Cancer"
July 16: "TAZ
Represents a Novel Therapeutic Target in NSCLC" (News-Medical.net)
14: "Combination
Drug Controls Tumor Growth and Metastasis" (Science 2.0)
Anti-Oxidants Elevate the Risk of Developing Cancer: Study
July 11, 2014 - Science World Report
Study Identifies Novel Genomic Changes in the Most Common Type of Lung Cancer
July 9, 2014 - National Institutes of Health
Novel Gene Mutations Linked to Common Lung Cancer ID'ed
July 9, 2014 - Monthly Prescribing Reference
Lung Cancer Study Hints at New Treatments
July 9, 2014 - Medical Xpress
Exposure to Low Doses of Arsenic Leads to Development of Cancer
July 9, 2014 - Science World Report
New Imaging Method May Be Better than Biopsies
July 8, 2014 - DOTmed
Brachytherapy with Sublobar Resection Fails to Improve NSCLC Recurrence Rates
July 4, 2014 - CancerNetwork.com
Japan Approves Roche's Alectinib for Form of Advanced Lung Cancer
July 4, 2014 - Reuters
IGF Inhibitor Adds No Benefit, Potentially Harmful in Advanced NSCLC
July 1, 2014 - CancerNetwork.com
Erlotinib No Better than Docetaxel in Advanced NSCLC
June 30, 2014 - Healio
Study Demonstrates Improved Diagnosis and Outcomes with LDCT
June 30, 2014 - Oncology Nurse Advisor
In Selected NSCLC Patients with Brain Metastasis, Be Aggressive
June 30, 2014 - Clinical Oncology News
Exhaled Breath May Help Identify Early Lung Cancer
June 30, 2014 - Domain-B.com
Enobosarm May Prevent Cancer-Induced Muscle Wasting in NSCLC
June 28, 2014 - OncLive
Researchers Closer to Helping Millions Battle Lung Cancer
June 26, 2014 - Drug Discovery & Development
Surgical Biopsy Proves Safe for Selected Late-Stage Lung Cancer Patients
June 26, 2014 - Newswise
Oncogenic Drivers in Lung Cancer
June 26, 2014 - CancerNetwork.com
Resistance to Targeted Therapy for Lung Cancer Can Be Reversed
June 25, 2014 - Oncology Nurse Advisor
J&J Innovation & Dana Farber Launch $10M Collaboration to Take Down Lung Cancer
June 24, 2014 - Bostinno
Research Identifies Potential New Treatment Approach for Lung Cancer
June 24, 2014 - Newswise
Chemo Combo Increases Survival, Toxicity in Sensitive Relapsed SCLC
June 23, 2014 - CancerNetwork.com
NaNose: Lung Cancer Gets a Breathalyzer Test
June 22, 2014 - Science 2.0
Study Ties Shorter Time to First Cigarette to Increased Risk of Lung Cancer
June 21, 2014 - Science World Report
UCLA Study Sheds Light on the Development of Lung Cancer
June 20, 2014 - News-Medical.net
Process Personalizes Treatment for Lung Cancer Patients
June 20, 2014 - Oncology Nurse Advisory
A New Tool to Confront Lung Cancer
June 19, 2014 - Science Codex
Docetaxel Plus Ramucirumab Improves Outcomes in Advanced NSCLC
June 19, 2014 - CancerNetwork.com
'Speed Dating' for Lung Cancer Drugs
June 17, 2014 - Drug Discovery & Development
More than 130 Lawmakers Urge Coverage for Lung Cancer Test that Could Cost Medicare Billions
June 17, 2014 - StarTribune
Greater Coverage of Lung Cancer Scans Backed
June 17, 2014 - Pittsburgh Tribune-Review
Women Underestimate Risk of Lung Cancer
June 17, 2014 - Pharmacy Times
MedImmune, Pharma Giants Launch Joint Genomics-Based Lung Cancer Trial
June 16, 2014 - Washington Business Journal
Lung Cancer Screening with LDCT Not Associated with Long Term Distress
June 16, 2014 - News-Medical.net
Improved Diagnostic Performance of Low-Dose Computed Tomography Screening
June 16, 2014 - Science Codex
New imaging software measures growth of nodules in patients at risk of lung cancer
June 13, 2014 - news-medical.net
Study of 'Super Responder' Reveals New Oncogene for Lung Cancer
June 13, 2014 - Medical Xpress
Survival Differences after Docetaxel, Erlotinib are EGFR Dependent
June 13, 2014 - Medwire News
Moffitt Research Assists Targeted Lung Cancer Therapy
June 12, 2014 - Suncoast News – New Port Richey
Living in Areas Polluted with Fine Particles Raises Lung Cancer Risk
June 12, 2014 - Environmental Health News
Resistance to Lung Cancer Targeted Therapy Can Be Reversed, Study Suggests
June 9, 2014 - Medical Xpress
Bevacizumab Added to Erlotinib Increases PFS in NSCLC
June 6, 2014 - CancerNetwork.com
Necitumumab Yields Small Benefit in Squamous Cell Lung Cancer
June 6, 2014 - CancerNetwork.com
New Gene Tests May Give Cancer Patients Quicker Path to Treatment
June 6, 2014 - Reuters
Researchers Report Double Dose of Promising Lung Cancer Findings
June 5, 2014 - Medical Xpress
Tumor Sequencing Offers New Insights for Management of Lung Cancer
June 4, 2014 - News-Medical.net
Novartis Study Shows Zykadia Reduces Tumors in Majority of ALK+ NSCLC Patients
June 4, 2014 - (Pharmaceutical Business Review
UCLA Scientists Take Brakes off Immune System to Fight Deadly Cancers
June 4, 2014 - HealthCanal
Researchers Develop Process to Help Personalize Treatment for Lung Cancer Patients
June 3, 2014 - Medical Xpress
Variations in BRCA2 and CHEK2 Genes Can Increase Lung Cancer Risk, Study Finds
June 3, 2014 - News-Medical.net
Breath Test May Help Detect, Assess Lung Cancer
June 3, 2014 - Monthly Prescribing Reference
'Liquid Biopsy' Offers New Way to Track Lung Cancer
June 3, 2014 - Science Codex
VIDEO: Ramucirumab Helps Prolong Advanced Lung Cancer Survival
June 2, 2014 - The Oncology Report
First Presentation of Data for Pembrolizumab, Merck's Investigational Anti-PD-1 Antibody, in Patients with Previously-Untreated, Advanced Non-Small Cell Lung Cancer:
NSCLC at ASCO 2014
June 2, 2014 - MarketWatch
Gold Nanoparticle Sensor-Based Test Can Detect, Distinguish Lung Cancer
June 2, 2014 - Azonano.com
Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation
June 2, 2014 - TheStreet
Gene Defect may Determine Likelihood of Lung Cancer in Smokers
June 1, 2014 - Science World Report
Eli Lilly Drug Prolongs Survival in Large Lung Cancer Trial
May 31, 2014 - Reuters
Genetic Alterations in Lung Cancer Help Select Treatment and May Improve Survival
May 30, 2014 - Oncology Nurse Advisor
Drug-Resistant Lung Tumors Respond to New Precision Therapy in Early-Stage Trial
May 30, 2014 - HealthCanal.com
Senators Push for Medicare to Cover Lung Cancer Test
May 29, 2014 - The Hill Blog
Researchers Create Tiny Artificial Lung
May 29, 2014 - RedOrbit
Final Thoughts on Improving Outcomes in NSCLC
May 29, 2014 - OncLive
ASCO: Chemotherapy Key Part of Curative Lung Cancer Therapies
May 29, 2014 - CancerNetwork.com
Why Would An 18-Year-Old Who Never Smoked Get Lung Cancer? The Answer
May 29, 2014 - Science 2.0
Lung Cancer Disparity: African Americans More Likely to Be Diagnosed
May 28, 2014 - The Washington Post Blog
Cancer Research Institute Announces Second Annual Cancer Immunotherapy Month
May 28, 2014 - Digital Journal
Lung Cancer Screening Abnormalities Prompted Smoking Cessation
May 28, 2014 - Healio
Lung Cancer: Advances in Current Treatment Modalities and Patient Classification
May 28, 2014 - New York Academy of Sciences
'Nanodaisies' Deliver Drug Cocktail to Cancer Cells
May 28, 2014 - Nanowerk
MedPage and CollabRx Introduce CancerRx to Help Oncologists, Pathologists
May 28, 2014 - News-Medical.net
Age-Related Lung Cancer Trends Seen in Women
May 27, 2014 - Oncology Nurse Advisor
Transgene Announces Promising Results in an Update from the Phase 2b Part of TIME Trial with TG4010 in Advanced Non-Small Cell Lung Cancer
May 27, 2014 - MarketWatch
Skeletal-Related Event Management in Lung Cancer
May 27, 2014 - OncLive
Artificial Lung the Size of a Sugar Cube (Nanowerk, 5/26/14)
Boulder's Clovis Oncology Earns Elite FDA Stamp (Colorado Hometown Weekly, 5/24/14)
US 'Proof-of-Concept' Trial Confirms Promise of Stratified Lung Cancer Treatment (HealthCanal, 5/23/14)
If We Can Cut the Leading Cause of Cancer Death, Shouldn't We? (The Hill, 5/22/14)
Researchers Aim to Speed Drug Approvals (Drug Discovery & Development, 5/22/14)
CT in the Operating Room Allows More Precise Removal of Small Lung Cancers (Oncology Nurse Advisor, 5/21/14)
Genprex Initiates Phase II Clinical Trial of Oncoprex for Late-Stage Lung Cancer Patients (News-Medical.net, 5/21/14)
Next-Generation Sequencing in Lung Cancer (OncLive, 5/20/14)
Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care (Memorial Sloane Kettering Cancer Center, 5/20/14)
SUVmax Predicts Outcome in Advanced NSCLC (MedwireNews.com, 5/16/14)
Phase I Study Reveals Abemaciclib Drug Shows Evidence of Single-Agent Activity in NSCLC Patients (News-Medical.net, 5/15/14)
Major Lung Resection Safest at High-Volume Hospitals (Oncology Nurse Advisor, 5/15/14)
Nationwide Screening Would Increase Lung Cancer Detection As Well As Costs (Healio, 5/15/14)
Modafinil Fails to Reduce Cancer-Related Fatigue (CancerNetwork.com, 5/13/14)
Amrubicin Promise for Etoposide-Naïve SCLC Patients (News-Medical.net, 5/12/14)
AZ Starts Pivotal Trials of Lung Cancer Immunotherapy (PMLive, 5/9/14)
ACR Now Accepts Applications for New Lung Cancer Screening Center Program (News-Medical.net, 5/9/14)
Chemotherapy Timing is Key to Success (MIT News, 5/8/14)
Lung Cancer Screening Program Expands to Offer Early Detection for High-Risk Construction Workers (Newswise, 5/8/14)
Failure to Support Medicare Coverage for CT Lung Cancer Screening May Have Lethal Consequences (Imaging Technology News, 5/7/14)
Experts Weigh in on Managing Elderly Patients with NSCLC (Oncology Nurse Advisor, 5/6/14)
ASTRO Urges Medicare to Provide National Coverage of Low-Dose CT Screening for Adults at High Risk for Lung Cancer (Newswise, 5/5/14)
Chemotherapy May Be Preferable Option in NSCLC with Wild Type EGFR (Healio, 5/3/14)
Panel Recommends against Low-Dose
CT for Lung Cancer in Medicare Patients (The Oncology Report, 5/1/14)
Precision Medicine for Lung Cancer Marks Tenth Anniversary (Dana-Farber Cancer Institute, 4/30/14)
A Breathalyzer for Lung Cancer May Be On Its Way (TIME, 4/29/14)
FDA Approves Zykadia for Late-Stage Lung Cancer (U.S. Food and Drug Administration, 4/29/14)
Poor QOL Doesn't Predict Low Survival in High-Risk Lung Cancer Patients Undergoing Surgery (Medical Xpress, 4/29/14)
Advances in Immunotherapy for the Treatment of Non-Small Cell Lung Cancer (OncLive, 4/25/14)
Study Examines Increase in Lung Cancer Risk from Combined Radon and Tobacco Smoke Exposure (Medical Xpress, 4/25/14)
Daiichi Sankyo Halts Lung Cancer Trial (Drug Discovery & Development, 4/25/14)
Blood Test Accurate in Later Stage Lung Cancer Diagnosis (Cancernetwork.com, 4/24/14)
Amrubicin and Cisplatin Inferior to Irinotecan Regimen for Small-Cell Lung Cancer (Cancernetwork.com, 4/23/14)
Genes May Predict the Need for Further Cancer Treatments (Oncology Nurse Advisor, 4/23/14)
Sublobar Resection as Effective as Lobectomy for Selected Early Lung Cancer Patients (MedwireNews, 4/23/14)
CR UK Partners with AZ, Pfizer for National Lung Matrix Trial (Pharma Times, 4/22/14)
New Clinical Trials Underway for Advanced Lung Cancer Patients (PBS/Public Broadcasting Service, 4/19/14)
Cancer Stem Cells Linked to Drug Resistance (Medical Xpress, 4/20/14)
Drug Combo May Knock Down Lung Cancer (U-T San Diego, 4/20/14)
Phase III Immunotherapy Lung Cancer Trial Stopped Early (CancerNetwork.com, 4/18/14)
Clinical Trial to Test Multiple Drugs (The Columbus Dispatch, 4/17/14)
Early Data in E-Cigarette Study May Raise Safety Concerns (The New York Times, 4/15/14)
Germline EGFR T790M Mutation Indicates a High Risk for Familial NSCLC Regardless of Smoking (Oncology Nurse Advisor, 4/17/14)
AbbVie's Lung Cancer Drug Advances to Phase 3 (Drug Discovery & Development Magazine, 4/15/14)
PET Imaging Before Surgery Reduces Unnecessary Lung Surgery by Half (Oncology Nurse Advisor, 4/15/14)
New Drug Successful against Crizotinib-Resistant, ALK-Positive Lung Cancer (Oncology Nurse Advisor, 4/14/14)
Immunotherapy Data Marks New Era for Treating Lung Cancer (Oncology Nurse Advisor, 4/14/14)
Researchers Identify Novel Compound Effective against Drug-Resistant Lung Cancer (News-Medical.net, 4/9/14)
Conventional Chemotherapy May Improve Advanced NSCLC Survival (Oncology Nurse Advisor, 4/9/14)
Simple Blood Test to Spot Early Lung Cancer Getting Closer (NPR/National Public Radio, 4/6/14)
Increased Risk of Developing Lung Cancer after Radiotherapy for Breast Cancer (ScienceCodex.com, 4/7/14)
Roche Lung Cancer Pill Gets Reprieve in UK Reversal (Reuters, 4/3/14)
UPDATE 1-GlaxoSmithKline Throws in Towel on Lung Cancer Vaccine Trial (Reuters, 4/2/14)
A New Drug Treats Lung Cancer (MedNewsAm, 4/2/14)
UT Southwestern Research Suggests Gene Study Can Determine Future Cancer Treatment Paths (BioNews Texas, 4/2/14)
Next-Generation EGFR Inhibitor Shows Promise in Resistant NSCLC (OncLive, 3/31/14)
Solid-Dominant Lung Cancer Histology No Barrier to Segmentectomy (News-Medical.net, 3/31/14)
Lung Cancer Patients' Sexual Dysfunction Needs More Attention and Treatment, Say Doctors (Medical Daily, 3/28/14)
Immune Therapy Continues to Advance in NSCLC (The Oncology Report, 3/28/14)
Gene that May Help Predict Whether Further Cancer Treatments are Needed Identified (HealthNewsDigest.com, 3/28/14)
FDA Approves Fiber-Optic Light Delivery System for Lung, Esophageal Cancer Treatment (BioOptics World, 3/27/14)
Novartis Says Lung Cancer Patients Respond to Drug in Study (Reuters, 3/27/14)
Discovery May Help Predict Lung Cancer Treatment Success (Drug, Discovery, and Development, 3/25/14)
Pfizer's Xalkori Extends Lung Cancer Survival (Drug, Discovery, and Development, 3/25/14)
Inherited Mutated Gene Raises Risk of Lung Cancer According to UTSW Researchers (BioNews Texas, 3/24/14)
Pfizer Lung Cancer Drug Beats Chemo for Previously Untreated Patients (Reuters, 3/25/14)
Endocyte Shares Double After Drug Shown to Slow Lung Cancer (Bloomberg Business Week, 3/21/14)
GSK disappointed with lung cancer treatment results, continues trial (Reuters, 3/20/14)
Researchers Discover New Mechanism Allowing Tumor Cells to Escape Immune Surveillance (newswise, 3/18/14)
A Photo a Day: One Year with Lung Cancer (Parade, 3/18/14)
Make cancer clinical trials smaller, smarter, more beneficial to patients, ASCO tells researchers (Cleveland.com, 3/17/14)
Findings reveal possible targets for small cell lung cancer (News-Medical, 3/17/14)
EML4-ALK fusion testing, targeted crizotinib treatment not cost-effective in NSCLC (HemOnc Today, 3/17/14)
School radon bill still alive but testing removed (The San Francisco Chronicle, 3/16/14)
Paris smog as bad as Beijing — free mass transit provided for three days (VIDEO) (NY Daily News, 3/15/14)
Potential new drug targets for aggressive form of lung cancer (Medical News Today, 3/13/14)
Tissue analysis near tumors holds hope for earlier detection, new treatments (News-Medical, 3/11/14)
Cancer Immunotherapy Race Stays Unpredictable (Daily Finance, 3/7/14)
Preop PET Cuts Lung Cancer Surgery (medpage Today, 3/7/14)
Researchers find antibody that may be used in future treatments for recurrent small-cell lung cancer (News-Medical, 3/5/14)
Bristol plans big lung cancer study, pairing immunotherapies (Reuters, 3/4/14)
Peregrine's Lead Agent Receives FDA Fast Track Designation for NSCLC (OncLive, 3/4/14)
Study identifies key protein that helps prevent lung cancer tumors from being destroyed (Medical Xpress, 3/4/14)
Exhaled Compounds Could Provide Accurate Lung Cancer Diagnosis (Cancer Network, 3/4/14)
Hormone therapy predicted improved lung cancer survival in women (The Oncology Report, 3/4/14)
Genentech study of drug combo on lung cancer halted (San Francisco Business Times, 3/3/14)
Lung Cancer Trials Soften Endpoint (MedPage Today, 3/3/14)
Doctors develop new way to more precisely pinpoint lung cancer (ABC30, 2/28/14)
Plasma microRNA test boosts lung cancer screening (medwireNews, 2/28/14)
Hormone therapy linked to better survival after lung cancer diagnosis in women (MedicalXpress, 2/26/14)
NY advocates urge funding to prevent lung cancer (The Wall Street Journal, 2/26/14)
Study of 'Super Responder' Reveals Possible New Gene Target for Lung Cancer (HealthNewsDigest.com, 2/25/14)
5 States Where Lung Cancer Rates Are the Highest (Daily Finance, 2/23/14)
Wine Kills Lung Cancer Cells in Lab Tests (The Wine Spectator, 2/21/14)
Smoking After Cancer: Does It Even Matter? (WebMD, 2/21/14)
Lilly lung cancer drug improves survival in late-stage trial (Reuters, 2/19/14)
The years lost to cancer (Washington Post, 2/17/14)
New therapies raise hope for a breakthrough in tackling cancer (Washington Post, 2/17/14)
Indoor exposure to radon gas may cause lung cancer (News-Medical, 2/14/14)
Breath test may detect lung cancer (USA Today, 2/9/14)
Lung cancer screening's slow start (Star Tribune, 2/8/14)
A Catalog of Cancer Genes That's Done, or Just a Start (The New York Times, 2/6/14)
Barnes-Jewish machine gives real-time view of tumors while delivering radiation (St. Louis Post-Dispatch, 2/6/14)
Lung cancer drugs erlotinib and gefitinib under review by NICE (Nursing Times, 2/4/14)
Global cancer deaths to hit 13 million per year in two decades, WHO warns (National Post, 2/3/14)
Let's Stop Judging Lung Cancer Patients … and make finding a cure the priority (Huffington Post, 2/2/14)
The role of immunotherapy in NSCLC to expand (The Oncology Report, 1/31/14)
Mesothelin expression prognostic in lung adenocarcinomas (News-Medical, 1/31/14)
New study raises questions about antioxidant use in lung cancer patients (The Washington Post, 1/29/14)
Pinpointing lung cancer (ABC7, 1/29/14)
Pfizer lung cancer drug fails in two large studies (Reuters, 1/27/14)
How Long Have I Got Left? (The New York Times, 1/24/14)
Keeping out drafts could mean more radon risk at home (Reuters, 1/23/14)
Imaging, biomarkers, clinical findings guide approach to indeterminate pulmonary nodules (The Oncology Report, 1/21/14)
Coming a Long Way on Smoking, With a Way to Go (The New York Times, 1/20/14)
Silica exposure may increases lung cancer risk (UPI, 1/11/14)
US is marking 50th anniversary of surgeon general report that turned the tide against smoking (StarTribune, 1/4/14)
Health experts: test for "silent killer" in your home (WEAU-TV, 1/2/14)
Task Force Recommends New Lung Cancer Screening Guidelines (KPBS, 1/2/14)
OSHA plans to slash silica workplace exposure limits (Reuters, 1/1/14)
Trebling tobacco tax 'could prevent 200 million early deaths' (Reuters, 1/1/14)
U.S. panel urges yearly CT scans for some heavy smokers (CBS News, 12/31/13)
Millions at high risk for lung cancer should be screened yearly, panel says (NBC News, 12/30/13)
Pfizer's XALKORI(R) Granted Regular FDA Approval (The Wall Street Journal, 11/21/13)
Go nuts! A handful a day may help you live longer, docs say (NBC News, 11/20/13)
Why Is Lung Cancer Rising Among Nonsmoking Women? (US News & World Report, 11/15/13)
Targeted Therapies Explored in Small Cell Lung Cancer (OncLive, 11/11/13)
Pneumococcal Pneumonia Linked to Lung Cancer Risk (NewsMedical, 11/11/13)
Specialist Lung Cancer Nurses Could Aid Treatment (NewsMedical, 11/11/13)
Genotyping Lung Cancer Linked to Better Survival (MedPage Today, 11/5/13)
Hopeful Glimmers in Long War on Cancer (The New York Times, 11/4/13)
The Pills of Last Resort: How Dying Patients Get Access to Experimental Drugs (The New York Times, 10/31/13)
Osteopontin level in early non-small cell lung cancer predicts recurrence (The Oncology Report, 10/31/13)
Stigma lingers for deadliest cancer (CNN, 10/30/13)
BUSM profs identify molecule to help aid lung cancer detection (Daily Free Press, 10/29/13)
Novel Target for Lung Cancer Treatment Discovered (Genetic Engineering & Biotechnology News, 10/29/13)
Lung cancer—killing tumors without chemo (ABC7 WWSB, 10/28/13)
Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 World Conference on Lung Cancer (Business Wire, 10/26/13)
Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers (Oncology Practice, 10/25/13)
GTx Presents Results from Enobosarm POWER Trials for the Prevention and Treatment of Muscle Wasting in Patients with Non-Small Cell Lung Cancer at 15th World Conference on Lung Cancer (The Wall Street Journal, 10/24/13)
Over 90 Percent in Europe's Cities Breathe Dangerous Air (The News Herald, 10/23/13)
AstraZeneca Starts Phase III Program for Lung Cancer Treatment (The Wall Street Journal, 10/22/13)
Genetic variant implicated in lung cancer development also linked with improved outcomes among affected patients (MedicalXpress, 10/18/13)
WHO agency: Air pollution causes cancer (USA Today, October 17, 2013)
Air pollution causes lung cancer, WHO agency announces (NBC News, 10/17/13)
Cancer: The blame game (The Independent, 10/15/13)
Boehringer Ingelheim submits nintedanib*, a novel oncology compound, for European approval (National Post, 10/14/13)
Myriad: MyPlan Lung Cancer Test Meets Primary Endpoint In Validation Study (NASDAQ, 10/28/13)
UPDATED: Bristol-Myers adds promising survival update on breakthrough cancer drug (Fierce Biotech, 10/26/13)
Diabetes drug Metformin with chemo and radiation may improve outcomes in lung cancer patients (Science Codex, 10/23/13)
Radon is the second leading cause of lung cancer (The Sentinel, 10/21/13)
PD-L1 inhibitor demonstrated activity in smokers with NSCLC (HemOnc Today, 10/11/13)
Immunotherapy induces 'striking' responses in non–small cell lung cancer (The Oncology Report, 10/9/13)
PET scan shows promise in predicting patients with inoperable lung cancer (News-Medical, 10/8/13)
MicroRNA-31 might predict lung cancer spread to lymph nodes (Oncology Nurse Advisory, 10/2/13)
Chemotherapy may be underused in elderly with lung cancer (Oncology Nurse Advisory, 10/2/13)
Older antidepressant may combat lethal lung cancer (HealthDay, 9/30/13)
Roche immunotherapy drug may be 'game changer' in lung cancer (Reuters, 9/29/13)
GIOTRIF® (afatinib)* approved in Europe for patients with EGFR mutation positive lung cancer (Financial Post, 9/25/13)
The arsenic in our drinking water (The New York Times, 9/20/13)
UT Southwestern Researchers Reveal Protein EGFR Hastens Tumor Growth and Chemotherapy Resistance (BioNews Texas, 9/19/13)
Could a blood test detect lung cancer early? (Los Angeles Times, 9/19/13)
Electronic nose sniffs out lung cancer (Medscape, 9/13/13)
Gene Mutation May Help Predict Lung Cancer Survival in Nonsmokers (US News & World Report, 9/12/13)
Software 'app' helps predict if lung lesions seen on CT are cancerous or benign: study (The Leader-Post, 9/5/13)
Survival between black and white lung cancer patients is similar (Science World Report, 9/4/13)
Doctors caution use of e-cigarettes, saying vaping is worse than smoking the real thing (ABC RTV6, 9/1/13)
Funds to support study of telephone-based treatment program for lung cancer patients (News-Medical, 8/28/13)
Improved Survival in Foreign-Born Hispanics With Lung Cancer (Cancer Network, 8/27/13)
Sequestration cuts hit Moffitt Cancer Center hard (Daily Loaf, 8/26/13)
Insight Genetics Awarded National Cancer Institute Contract to Advance Lung Cancer Diagnosis and Treatment (Herald Online, 8/26/13)
Obama administration proposes new standards for silica dust (Los Angeles Times, 8/23/13)
Uneven accessibility to biomarker test for lung cancer (CMAJ, 8/23/13)
Is This Experimental Lung Cancer Drug Back on Track? (Daily Finance, 8/22/13)
Tumor measurements predict survival in advanced non-small cell lung cancer (Medical Xpress, 8/19/13)
Aspirin tied to smaller lung and colon cancer tumors (Reuters, 8/16/13)
Lung cancer screening recommendation could affect DoD, VA care (Air Force Times, 8/16/13)
A Lilly Lung Cancer Drug Provides a Welcome Surprise (Forbes, 8/13/13)
Eating raw garlic may help cut risk of lung cancer almost in half, study finds (Fox News, 8/9/13)
Discovery May Help Pinpoint Risk of Lung Cancer Returning After Surgery (US News & World Report, 8/7/13)
New study focuses on link between lung cancer and a region's pollution (Naperville Sun, 8/3/13)
R.J. Reynolds Tobacco Company Loses $37.5 Million Battle Over Lung Cancer Victim (Huffington Post, 8/2/13)
Air Pollution Linked to Lung Cancer and Heart Failure (Guardian Express, 7/31/13)
U.S. proposes annual lung cancer screening for those at high risk (Los Angeles Times, 7/30/13)
Influential Federal Panel Backs CT Scans for Lung Cancer (The Wall Street Journal, 7/29/13)
First Major Study of Cancer Incidence in Asian Americans (Asian Scientist, 7/29/13)
Effect of obesity on patients with advanced non-small cell lung cancer (Science Codex, 7/25/13)
Crizotinib Ups PFS in ALK-Positive NSCLC (Science Codex, 7/25/13)
Need for national Canadian strategy for EGFR testing (MedicalXpress, 7/25/13)
New York's Indoor Smoking Ban Hits 10-Year Mark: Where Do Other States Stand on the Issue? (Medical Daily, 7/22/13)
Greenville Lung Cancer survivor featured in "Cosmopolitan" (WNCT9, 7/19/13)
PET improves survival in limited-stage [small cell] lung cancer (Oncology Nurse Advisor, 7/17/13)
Lung cancer 'secrets' to be probed (BBC, 7/17/13)
Lung cancer screening most useful in high-risk people (Reuters, 7/17/13)
Late Stage Lung Cancer Drug Gilotrif (Afatinib) Approved By FDA (Medical News Today, 7/13/13)
Public Health England to launch largest cancer database (BBC, 6/12/13)
Pollution linked to lung cancer, heart failure increases (CBS News, 7/10/13)
"Jeopardy!" champ "Watson" now in training to fight cancer (CBS News, 7/9/13)
Lung cancer warning: 'Don't ignore persistent cough' (BBC, 7/1/13)
Many cancer patients expect palliative care to cure (Reuters, 6/26/13)
Lists of cancer mutations awash with false positives (Nature, 6/17/13)
ASCO: Melanoma Tx May Be Option in Lung Cancer (medpage Today, 6/5/13)
ASCO: TKI Offers Hope in Small Cell Lung Cancer (medpage Today, 6/5/13)
ASCO: Boehringer's nintedanib boosts survival in lung cancer subset (PM Live, 6/5/13)
ASCO: Immune Therapy Active Against NSCLC (medpage Today, 6/5/13)
Spray Tanning May Cause Lung Cancer, Warn Researchers (Medical Daily, 6/5/13)
Promising New Cancer Drugs Empower the Body's Own Defense System (The New York Times, 6/3/13)
New Drug May Help Fight Certain Advanced Lung Cancers (US News & World Report, 6/3/13)
Novel Agent Shows Potential for Advanced Lung Cancer (Medscape News Today, 6/3/13)
Merck Rushes Forward In Race To Market Cell Death Cancer Drugs (Forbes, 6/2/13)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer (New England Journal of Medicine, 6/1/13)
Targeted therapy boosts lung cancer outcomes (MedicalXpress, 6/1/13)
Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study (The Wall Street Journal, 6/1/13)
Promising New Therapy For Lung Cancer (Medical News Today, 6/1/13)
Treatment of lung cancer using nanoparticle drug delivery systems (Current Drug Discovery Technology, 6/1/13)
Immunotherapy is not just for melanoma anymore (Reuters, 5/31/13)
FDA Debates on Lung-Cancer Warning for Blood-Pressure Drugs (CNBC, 5/31/13)
Father and son to present their respective cancer research at ASCO (MedicalXpress, 5/29/13)
New method for predicting cancer virulence developed (MedicalXpress, 5/26/13)
Lung cancer screening: CT scans more effective than X-rays (Fox News, 5/23/13)
NLST Reveals Details of First Round of Lung Cancer Screening (Medscape, 5/22/13)
Research offers promising new approach to treatment of lung cancer (MedicalXpress, 5/22/13)
Racial Disparities Seen in U.S. Lung Cancer Treatment (Philadelphia Inquirer, 5/21/13)
ASCO: Midlife fitness may protect against lung cancer (Oncology Nurse Advisor, 5/20/13)
LUX Program Examines Pan-HER Inhibitor Afatinib in Multiple Tumor Types (OncLive, 5/17/13)
Lung biomarker testing hindered by insufficient tissue samples (Oncology Nurse Advisor, 5/17/13)
Lung Cancer, Not One Disease: Diverse Patients Need Personalized Treatments, Two New Studies Show (Sacramento Bee, 5/16/13)
Standard-dose radiation bests high-dose radiation in advanced NSCLC (The Oncology Report, 5/16/13)
FDA approves Astellas-Genentech lung cancer drug, diagnostic test (Chicago Business Journal, 5/15/13)
FDA approves Roche diagnostic for gene mutation in lung cancer (CNBC, 5/14/13)
Anti-HER2 treatments may benefit some patients with lung cancer (Oncology Nurse Advisor, 5/14/13)
Human Immune-Boosting Cancer Drugs Seen Extending Lives: Health (Bloomberg News, 5/13/13)
In NSCLC, Beta-3 Tubulin Isoform Does Not Predict Treatment Response to Ixabepilone, Paclitaxel (Cancernetwork.com, 5/13/13)
Black Lung Disease Rates Rise Among Appalachian Miners (Medical Daily, 5/13/13)
Lung Cancer Screening (JAMA Network, 5/8/13)
Advances in lung cancer treatment have major impact on short- and long-term outcomes (NewsMedical, 5/8/13)
New Lung Cancer Guidelines Recommends Offering Screening To High-Risk Individuals (ChestNet.org, 5/7/13)
Doctors to older, heavy smokers: Get CT screening for lung cancer (Reuters, 5/7/13)
More non-smoking, young women developing lung cancer (NBC11 Alive, 5/7/13)
Novartis Boost Seen in Fast Approvals as Protection Ends: Health (Bloomberg News, 5/5/13)
New computational method for assessing lung cancer tumors (NewsMedical, 5/3/13)
New, More Accurate Way of Imaging Lung Cancer Tumors (Science Daily, 5/2/13)
Diabetes drug can stop cancer cell growth, report suggests (CBC News, 5/1/13)
Rising Cancer Cases in Latin America (The Guardian Express, 4/27/13)
Variations on a Gene, and Tools to Find Them (The New York Times , 4/27/13)
Testing Lung Cancer Patients for Gene May Aid Treatment, Study Finds (U.S. News & World Report, 4/22/13)
HER2-Positive NSCLC Yields to Targeted Agents (Medpage Today, 4/22/13)
Department of Defense Lung Cancer Research Program Fiscal Year 2013 Strategic Plan (CDMRP website, 4/19/13)
Icy Therapy Spot Treats Cancer in the Lung (Science Daily, 4/14/13)
Study hints of links between HPV and lung cancer (Courier-Journal.com, 4/12/13)
Carol Burnett on cancer: Comedian talks about losing daughter to lung cancer (Examiner.com, 4/11/13)
Low levels of serum bilirubin spell higher lung cancer risk for male smokers (MedicalXpress, 4/7/13)
Artificial Intelligence Comes to Cancer Care (Clinical Oncology News, 4/7/13)
Advances in Molecular Testing Offer New Hope for Lung Cancer Patients (Science Daily, 4/3/13)
Many doctors do not provide tobacco cessation assistance to lung cancer patients (MedicalXpress, 3/28/13)
New Research Suggests Lung Cancer Spreads Like Info On The Web (KPBS, 3/27/13)
Soy tied to better lung cancer survival among women (Reuters, 3/26/13)
PLCO criteria catch more lung cancers (The Oncology Report, 3/20/13)
Novartis lung cancer drug gets key FDA designation (Bloomberg Businessweek, 3/15/13)
High Tech Approach To Treat Lung Cancer (CBS Boston, 3/12/13)
Faster approval for new cancer drugs saving lives (NBC News, 2/25/13)
ACS introduces lung cancer screening guidelines (Oncology Nurse Advisor, 2/21/13)
Optimal lung cancer screening nodule size questioned (NewsMedical, 2/19/13)
IKBKE gene plays a key role in tobacco-induced lung cancer (News-Medical.net, 2/16/13)
Study helps define role of early palliative services in lung cancer (Oncology Nurse Advisor, 2/14/13)
Lung cancer 'overtaking breast cancer in European women' (BBC, 2/12/13)
IBM's Watson tackles lung cancer (Newsday, 2/12/13)
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials (Journal of Clinical Oncology, 2/11/13)
IBM's Watson is better at diagnosing cancer than human doctors (Wired, 2/11/13)
Doctors call on supercomputer Watson to help fight cancer (NBC News, 2/8/13)
The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell Lung Cancer (Journal of Thoracic Oncology, 1/30/13)
EGFR doesn't predict outcomes in lung cancer (Oncology Nurse Advisor, 1/25/13)
Women's lung cancer death rate almost the same as men's (CBS News, 1/23/13)
Boehringer Ingelheim's lung cancer compound granted FDA Priority Review (PharmaPhorum, 1/17/13)
Study Links Highly Segregated Counties and Lung Cancer Deaths in Blacks (The New York Times, 1/16/13)
Cancer Rate Soaring, New Chinese Report Reveals (The Epoch Times, 1/15/13)
Reduce Lung Cancer Risk in 2013 by Testing Your Home for Radon Gas / Elevated radon levels found in roughly 1 in 15 homes nationwide (EPA, 1/14/13)
Simple radon test can help prevent lung cancer (Fairbanks Daily News-Miner, 1/14/13)
Indoor air pollution and risk of lung cancer among Chinese female non-smokers (Cancer Causes Control, 1/12/13)
Smoker? Ex-smoker? Cancer group says yearly CT scan may be advisable (Los Angeles Times, 1/11/13)
Common Heart Drug Might Improve Lung Cancer Survival (MedLinePlus, 1/9/13)
FDA grants 'fast track' status to GTx lung cancer drug (Memphis Business Journal, 1/8/13)
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care (Journal of Clinical Oncology, 1/7/13)
Oncology Group Reaches Out to Primary Care (MedPageToday, 1/4/13)
Pancreatic, other dire cancers get a legislative nudge: Recalcitrant Cancer Research Act Signed Into Law (LA Times, 1/4/13)
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid (Journal of Thoracic Oncology, December 2012)
Oncothyreon lung cancer drug fails in late-stage trial (Reuters, 12/19/12)
EPA tightens soot rules by 20 percent (Washington Post, 12/14/12)
Meat raises lung cancer risk, too, study finds (Reuters 12/10/12)
Denosumab extended survival in lung cancer with bone metastases (Oncology Nurse Advisor, 12/6/12)
Dogs can sniff out lung cancer, pilot study shows (MedicalXpress,12/5/12)
Selumetinib plus docetaxel shows KRAS-mutant NSCLC potential (Medical News, 12/3/12)
Anticancer Drug Benefits Persist with Local Treatment (MedPage Today, 12/1/12)
November 29, 2012
Tumor tracking technique may improve outcomes for patients with lung cancer (Oncology Nurse Advisor)
November 27, 2012
Researchers find evidence of 'chemo brain' (NBC Nightly News)
November 26, 2012
Colorful Fruits, Vegetables May Be Key to Cancer-Fighting Diet (US News & World Report)
November 26, 2012
Grapefruit, Medicine Interaction Warning Expanded (ABC News)
November 20, 2012
Smokers, Nonsmokers Alike Urged to Learn About Lung Cancer (US News & World Report)
November 15, 2012
Five Things to Know About Lung Cancer (Patch.com)
November 15, 2012
Lung Cancer Lags in Research Funding (The Orange County Register)
November 15, 2012
Smokeout Day 2012: Realities Behind the New Numbers (Huffington Post)
November 13, 2012
Lung Cancer Odds Better with Gene Test (San Francisco Chronicle)
November 12, 2012
Misunderstanding Chemo (The New York Times)
November 11, 2012
Gene Variations Linked to Lung Cancer Susceptibility in Asian Women (NIH News)
November 9, 2012
Lung Cancer Awareness Month: What We Can Learn From Celebrities Touched By The Disease (Huffington Post)
November 9, 2012
Lung Cancer Awareness Highlights Dangers Of Radon Gas (The Daily Tribune News)
November 8, 2012
Radon, The Second Leading Cause Of Lung Cancer After Smoking (The Sacramento Bee)
November 8, 2012
Great American Smokeout: November 15 (UPI)
November 2, 2012
Veterans Not Told of Lung Cancer Risk (WISHTV)
November 2, 2012
Toxicity Shuts Down Avastin Trial in NSCLC (MedPage Today)
October 29, 2012
Advanced Lung Cancer Patients Likely to Misunderstand Treatment (Los Angeles Times)
October 29, 2012
Platinum Doublet Effective in NSCLC (MedPage Today)
October 26, 2012
Metformin May Boost Lung Cancer Survival (MedPage Today)
October 25, 2012
Most patients with incurable cancer still think they'll survive, study finds (CBS News)
October 23, 2012
IBM Watson Finally Graduates Medical School (Information Week)
October 17, 2012
Lilly's Alimta Approved in Continuation Maintenance for a Type of Lung Cancer (Fox Business)
October 12, 2012
US FDA Approves Celgene's Abraxane for lung cancer (Chicago Tribune)
October 11, 2012
With Lung Cancer, Quitters Do Better Than Smokers (Reuters)
October 10, 2012
New Breath Rest Could Diagnose Chronic Disease and Cancer (CBS This Morning)
October 10, 2012
Blood Test May Spot Rare Lung Cancer: Marker in plasma rises when asbestos-linked mesothelioma is present, study says (US News & World Report)
October 9, 2012
10 Breast Cancer Myths - Busted (Parade)
October 8, 2012
Scientists Link Gene to Lower Risk of Lung Cancer: Inflammation may be a disease factor, researcher says (HealthDay News)
October 5, 2012
PET predicts lung cancer survival, may help individualize treatment (HealthImaging)
October 2, 2012
Cancer treatment speeded by genome superhighway (Reuters)
October 1, 2012
Breakthrough in Understanding Lung Cancer Vulnerabilities Points the Way to New Targeted Therapy (Science Daily)
September 30, 2012
Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say (Bloomberg)
September 25, 2012
Seeking Cures, Patients Enlist Mice Stand-Ins (The New York Times)
September 21, 2012
Launching a new war on cancer (CNN)
September 21, 2012
Nation's largest cancer hospital, in Texas, plans 'moonshot' against 8 forms of the disease (The Washington Post)
September 20, 2012
House Approves Cancer Bill (New Jersey Today)
September 14, 2012
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers (Cell)
September 13, 2012
Studies offer 'panoramic view' of lung cancer--Three genome-sequencing trials may help to revamp treatments for the world's most deadly cancer (Nature)
September 13, 2012
Lung cancer tumours in smokers have 10-times more genetic mutations (EarthTimes)
September 10, 2012
Matthew Meyerson discusses TCGA lung squamous cell cancer study (NCI's Benchmarks)
September 9, 2012
Cancer Study Points to Tighter Pairing of Drugs and Patients (The New York Times)
September 6, 2012
Lilly: Alimta regimen didn't meet goal in study (CBS News)
September 5, 2012
Bits of Mystery DNA, Far From 'Junk,' Play Crucial Role (The New York Times)
September 5, 2012
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR mutant lung cancers that lack the second-site EGFR T790M mutation (Cancer Discovery)
August 31, 2012
Risk of lung cancer associated with domestic use of coal in Xuanwei, China (BMJ)
August 27, 2012
VA to try 'phased' approach to lung cancer CT screening (DOTmed news)
August 24, 2012
U.S. appeals court rejects graphic anti-smoking warnings (Los Angeles Times)
August 24, 2012
Lilly wins appeal upholding patent For Alimta cancer drug (Bloomberg)
August 22, 2012
Underfunded, undertreated: Lung cancer in nonsmokers on the rise (Chicago Tribune)
20, 2012
Risk tool may ID patients for CT lung scans (medpage Today)
August 20, 2012
Physicians face multiple challenges in combating cancer disparities (American Medical News)
August 17, 2012
Radon linked to more lung cancer deaths than previously thought (CBC News)
August 7, 2012
How chemotherapy may trigger tumors' resistance (Time)
August 2, 2012
Six hospitals join CoC ProvenCare Lung Cancer Collaborative (News Medical)
July 29, 2012
'Greyjing'? Air pollution fouls Beijing's name (Chicago Tribune)
July 25, 2012
The anxiety of waiting for test results (New York Times)
July 11, 2012
Heavy smokers should get annual CT screening, thoracic surgeons say (American Medical News)
July 9, 2012
Firms test nanotechnology to deliver cancer drugs (The Boston Globe)
July 9, 2012
Radon budget cuts will hurt Utah, state warns (The Salt Lake Tribune)
July 9, 2012
Memphis researcher gets $3 million for lung cancer study (The Commercial Appeal)
July 5, 2012
Women more likely to die of lung cancer (Irish Examiner)
June 27, 2012
Women's lung cancer deaths up in parts of U.S.: study (Chicago Tribune)
June 21, 2012
Science lacking on 9/11 and cancer, experts say (USA Today)
June 19, 2012
Pfizer says lung cancer drug meets study goal (Bloomberg)
June 16, 2012
EPA proposes more stringent soot rules (Los Angeles Times)
June 15, 2012
Secondhand smoke tied to more health effects (Fox News)
June 13, 2012
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review (The Journal of the American Medical Association)
June 12, 2012
W.H.O. Declares Diesel Fumes Cause Lung Cancer (The New York Times)
June 8, 2012
Sept. 11 Health Fund Given Clearance to Cover Cancer (The New York Times)
June 6, 2012
Antibody alarm call rouses immune response to cancer (Nature)
June 6, 2012
Calif. voters split on tax targeted by Big Tobacco (USA Today)
June 4, 2012
Bristol Immune Drug Success in Cancer May Spur Industry Race (Business Week)
June 4, 2012
Boehringer plans to challenge lung cancer drugs (Reuters)
June 2, 2012
Experimental drug trains immune system to shrink tumors (ABC News)
May 24, 2012
CDC: States make billions from tobacco taxes and lawsuits, but spend little on smoking prevention (CBS News)
May 23, 2012
NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care (OncLive)
May 23, 2012
Chemo-Radiation Combo Extends NSCLC Survival (MedPage)
May 22, 2012
Bayer, Onyx cancer drug fails in late-stage study (Associated Press)
May 20, 2012
Lung cancer screening guidelines updated (USA Today)
May 9, 2012
Doctors troubled by rise in lung cancer in non-smokers (CTV Edmonton)
May 7, 2012
Ricky Gervais and Alex Ferguson lead lung cancer awareness campaign (Metro)
May 5, 2012
Women who don't smoke can still get lung cancer (Chicago Tribune)
May 4, 2012
Older Lung Cancer Patients Less Likely to Be Treated (US News & World Report)
April 25, 2012
Air Pollution Endangers 41 Percent of Americans, Lung Association Report Finds (National Journal)
April 24, 2012
The 'Hispanic paradox': Latinos and lung cancer (LA Times)
April 23, 2012
Aspirin tied to lower lung cancer risk in women: study (Reuters)
April 17, 2012
Avastin Fails to Help Older Lung-Cancer Patients in Study (Bloomberg)
April 13, 2012
Lung Cancer Rates in Women Are 'Rising' (The Independent)
April 11, 2012
Lung Cancer Stigma Compromises Care, Study Says (CTV News)
April 10, 2012
Analysis Finds Lung Cancer Screening Worthwhile For Longtime Smokers (NPR)
April 9, 2012
An Actuarial Analysis Shows That Offering Lung Cancer Screening as an Insurance Benefit Would Save Lives At Relatively Low Cost (Health Affairs)
April 8, 2012
Federal Health Officials Encouraged by Response to Anti-Smoking Ads (Las Vegas Review-Journal)
April 8, 2012
Why Joe Camel and Youth-Targeted Tobacco Ads Should Be Banned (Culture Map Austin)
March 28, 2012
Lung Cancer Advances Drive Better Prognosis (Toronto Star)
March 28, 2012
Quality of Life Tied to Lung Cancer Survival (Reuters)
March 28, 2012
The Radon Threat Is Still With Us (New York Times)
March 27, 2012
Old Age Affects Advanced-Stage Cancer Diagnoses Differently (Medscape)
March 26, 2012
Lower Dosage CT-guided Lung Biopsy May Reduce Overall Lung Cancer Deaths (Diagnostic Imaging)
March 25, 2012
ASCO: Integrate Palliative Care into Standard Oncology Care (Oncology News)
March 29, 2012
UK Asbestos Ruling Clears Way for Insurer Payouts (ABC News Australia)
March 22, 2012
Lung Cancer Screening Programme Trial for Scotland (BBC)
March 23, 2012
Stigma Linked to Depression Among Lung Cancer Patients (Medical Xpress)
March 22, 2012
NCCN Reaffirms Lung Cancer Screening of Heavy Smokers (Family Practice News)
March 20, 2012
Studies Link Daily Doses of Aspirin to Reduced Risk of Cancer (New York Times)
March 19, 2012
Early Lung Cancer Screenings for Smokers Leave More Questions (USA Today)
March 15, 2012
Study: Smoking Laws Prevented 800,000 Lung Cancer Deaths (Chicago Tribune)
March 8, 2012
Cancer Scans May Give False Picture of Genes Driving Disease (Bloomberg)
March 5, 2012
Lung Cancer Risk Increases with Diesel Exhaust Exposure (CBS News)
February 29, 2012
HIV as an Independent Risk Factor for Incident Lung Cancer (AIDS online)
February 29, 2012
U.S. Judge Strikes Down F.D.A. Cigarette Labels (NY Times)
February 27, 2012
Drug May Be Near for Cancer's Companion Condition Cachexia (Los Angeles Times)
February 23, 2012
Cancer-Drug Shortages Targeted by Stopgap U.S. Approvals (San Francisco Chronicle)
February 23, 2012
New Drug Helps Patients Survive Lung Cancer (KABC-TV Los Angeles)
February 23, 2012
Longer Cancer Referral Times for Young, Women and Ethnic Minorities (BBC News)
February 21, 2012
A Novel Classification of Lung Cancer into Molecular Subtypes (PLoS One)
15, 2012
Roche Warns of Counterfeit Cancer Drug in US (Boston Globe)
February 13, 2012
Radiation After Lung Cancer Surgery Doesn't Help All: Study (US News & World Report)
February 8, 2012
9/11 First Responders See Cancer Rates Triple (Huffington Post)
February 6, 2012
ASCO: Why Cancer Care and Palliative Care Should Be Combined (Wall Street Journal)
February 6, 2012
American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care into Standard Oncology Care (Journal of Clinical Oncology)
27, 2012
Gene Test May Aid Early-Stage Lung Cancer Patients (San Francisco Chronicle)
January 27, 2012
'Desperate Housewives' Kathryn Joosten talks Lung Cancer, and how to fight back
January 23, 2012
Smokers with Cancer Benefit from Quitting, but Need Extra Help (Harvard Health Journal)
January 13, 2012
Cancer Treatment: Are Personalized Molecular Profiles in Our Future? (PBS Newshour)
January 12, 2012
Generalizing Lung-Cancer Screening Results (New England Journal of Medicine)
January 12, 2012
Federal Radon Action Plan--Federal Partners Release Scorecard: An Early Look (EPA)
January 11, 2012
Local Health Officials Warn About Radon: The gas is the second-leading cause of lung cancer in the United States: western geology can cause elevated levels (Denver Post)
January 11, 2012
Tests Might Someday Help Spot Early Lung Cancer (US News & World Report)
January 10, 2012
Mixed News on Tough-to-Treat Lung Cancer (US News & World Report)
January 9, 2012
Researchers Look at Genomes of Nonsmokers With Lung Cancer (US Dept of Health & Human Services)
January 9, 2012
Anti-Estrogen Treatment Shrank Lung Tumors in Mice (US News & World Report)
January 4, 2012
Fewer Americans Dying of Cancer, American Cancer Society Says (CBS News)
January 3, 2012
Chris Draft, NFL Retiree, Buries Wife One Month After Wedding, Sheds Light On Lung Cancer Among Non-Smokers (Huffington Post)
31, 2011
Health Experts Warn of 'Silent Killer' ... Radon (Connecticut Post)
December 30, 2011
New Illinois Law Will Let Tenants Get Information on Radon Testing in Homes (Chicago Tribune)
December 27, 2011
Breath Test Accurately Detects Lung Cancer Better Than 80 Percent (Today's THV)
22, 2011
EPA to Crack Down on Dirty Power Plants: Long overdue national standards rein in the largest remaining source of uncontrolled toxic pollution in the U.S. (U.S. News & World Report/AP)
21, 2011
NCI's Varmus Changes the Metaphor: There Is No War on 'Cancer' (Medscape)
20, 2011
Developing Lung Cancer Screening Strategies (daily Rx)
11, 2012
The Ferrari of Cancer Treatments: New Radiotherapy Machine Which Can Destroy Brain Tumours... and Even Restore Sight (Daily Mail)
7, 2011
Targeted Drugs, Lung Screening Top Cancer Advances in 2011 (USA Today)
December 1, 2011
WellPoint to Cover Lung CT Scan for Heavy Smokers (Wall Street Journal)
November 14, 2011
Kathryn Joosten Speaks Out About Lung Cancer Profiles; 'Desperate' to Share Her Personal Lung Cancer Story to Help Others
November 7, 2011
ASCO Releases Blueprint for Cancer Research in Next Decade (CancerProgress.Net)
November 4, 2011
FDA Officials Hail Increased Drug Approvals (New York Times)
October 26, 2011
Study: Lung Cancer X-Ray Screenings Have No Benefit (CBS News)
September 24, 2011
Avastin and pemetrexed combination gives lung cancer patients significantly more time without their disease progressing
September 20, 2011
American Association for Cancer Research Calls on Congress to Provide Critical Funding Increases for Life-saving Research Supported by the NIH and NCI
June 29, 2011
Reduced Lung Cancer Mortality with Low-Dose Computed Tomographic Screening (New England Journal of Medicine)
See LUNGevity's response to this study:
LUNGevity Applauds Results of Nationwide Study
June 3, 2011
Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse (Reuters)
May 24, 2011
Pfizer Oncology Launches "Cancer: It's Personal"
May 18, 2011
MetMAb in Combination with Tarceva Doubled the Time People with Lung Cancer Lived without Their Disease Getting Worse (Genentech press release)
May 18, 2011
Pfizer lung cancer drug shows survival benefit (Reuters)
March 23, 2011
Lung Cancer Evolves With Treatment, Study Finds:Genetic changes in response to therapy may cause some tumors to become drug-resistant (U.S. News and World Report)
January 25, 2011
Can You Guess What's Holding Back U.S. Longevity? (Wall Street Journal)
January 3, 2011
Blood test to spot cancer gets big boost from J&J (Wall Street Journal)
December 17, 2010
Australian Docs Claim Breakthrough in Lung Cancer Cure (TopNews)
December 15, 2010
Gene linked to some smokers' lung cancer (Science News)
December 15, 2010
New Treatment Targets Gene in Difficult Lung Cancers (My Health News Daily)
October 11, 2010
Erlotinib Trumps Chemo in Advanced NSCLC With EGFR Mutations (Internal Medicine News)
October 10, 2010
New Pfizer drug may add to mix in lung cancer war (Reuters)
October 7, 2010
Cheek Swab May Detect Lung Cancer (U.S. News and World Report)
October 6, 2010
NIH awards New Innovator grant for lung function CT program (HealthImaging.com)
October 5, 2010
Women and Lung Cancer: A 21st Century Epidemic (EmpowHER)
October 5, 2010
Many New Lung Cancer Drugs Expected This Decade (RTT News)
September 10, 2010
Reprogramming Cancer Cells (CBS Evening News)
September 2, 2010
Diabetes drug may keep lung cancer at bay (Reuters)
August 24, 2010
Pfizer's Sutent Fails to Improve Survival in Lung Cancer Patients (FOX Business)
August 18, 2010
Palliative Care Extends Life, Study Finds (New York Times)
August 13, 2010
Estrogen-only therapy may not up lung cancer deaths (Reuters)
Biotechs See Promise in Viral Treatments Cancer (Wall Street Journal)
August 3, 2010
Bobby Hebb, signer of '66 hit 'Sunny' dies at 72 (MSBNC.com)
July 21, 2010
New Treatment Helping Woman Beat Rare Cancer (WCVB-TV5, Boston, MA)
July 20, 2010
Avastin Largely Safe for Patients with Type of Advanced Lung Cancer (U.S. News and World Report)
July 19, 2010
Testing for Lung Cancer Genes (NY Times)
July 15, 2010
20% of Women with Lung Cancer Don't Smoke (KDKA, Pittsburgh, PA)
July 12, 2010
Blame's Net Catches Lung Cancer Patients (NY Times)
July 9, 2010
Merck KGaA Seeks Second Cancer Vaccine in BB Biotech Vaximm Joint Venture (Bloomberg)
June 7, 2010
Pill shrinks some lung cancer (WebMD)
Crizotinib shows great promise in non-smokers' lung cancer (USA Today)
Abraxis' Abraxane meets cancer study goal (Business Week)
Pfizer Drug Shows Promise in Lung Cancer with a Genetic Twist (Wall Street Journal)
June 6, 2010
Many Cancer Drugs, Hardly Any Breakthroughs (Forbes)
June 4, 2010
Researchers test lung cancer vaccine (WAVYTV, Portsmouth, VA)
June 2, 2010
WHO predicts 21 million annual cancer cases by 2030 (CNN.com)


text:
Is Zuckerberg about to up the stakes in Facebook's bitter battle with Google?
Facebook is holding yet another event next Monday and already speculation is rife about just what Zuckerberg and co will have to show the assembled crowd of hacks and social media fanatics.
The gathering, which kicks off at 5.30pm UK time on 15 November, could see the official unveiling of 'Project Titan', the hotly-tipped webmail offering which Facebook is hoping will rival Google's peerless Gmail.
Why? Well the invite clearly shows Facebook's iPhone inbox icon. Tenuous, sure, but it's enough to get tech fanatics salivating at the prospect of yet another front opening in Google and Facebook's acrimonious battle for web supremacy.
Mark Zuckerberg has already said that Facebook will be touting one more major product in 2010. Here's hoping it's not just a minor tweak to its mobile site and something massive.
What has Facebook got up its sleeve? Let us know what you think on our Facebook and Twitter pages now.
Via TechCrunch

subset: commoncrawl


text:
|101 posts found
Elite Member
Joined: 1/06/05
Originally posted by kadepsyson
That's a very cynical way of looking at it.
It's getting to be that small developers "can't win for losing."
If they get larger amounts of money from publishers then those publishers are going to want a certain level of return for their investment and will put pressure on the developers. Developers more often than not change the way the game is being developes and it becomes a sanitized mess and then the players complain.
Developers don't take publisher's money, scrape together enough to make some sort of game but there are holes, bugs, they need to release or the entire thing will fall flat and it just isn't good enough and players complain.
It seems that players want developers to:
put in millions upon millions of dollars to make a AAA game BUT make it so the game is innovative, different and incorporate features that push the boundaries of game development and then be satisfied with a smaller die hard crowd who might not be able to keep the game running.
And if the game fails? Then players want the developers to do it all again.
Where is the developre's incentive? The rebuttal to that is "no, we just want developers to make good, fun games". well, I believe all developers want to make good fun games. But they need money to do it . It's "rock and a hard place".
This whole kickstarter things is not about "paying for beta". That's something else. This is an investment in making a product that would not get made or would have a slimmer chance of getting made without the additional funds.
Since the individual amounts are so small, any financial return would also be small if not negligable, therefore, besides being part of the process the investors not only get a product they want that would not have been made because of such a small group of interested players, but they get some sort of thanks.
they being in beta is more about them being part of the process. Most players will never have the ability to make a video game. Now they can be part of the team, the backers, and get something that they help create.
The only problem I see is when you get players that are so excited and not very wise and they invest thousands of dollars that they shouldn't be investing only to get something that was less than what they wanted.
few people aspire to work at mcdonald's simply for the incredible life experience that it gives. Many people are not creative, do not have talent or knowledge and would never be able to create something that they love and are invested in. This gives them that chance.
Login or Register to never see this panel
Novice Member
Joined: 1/16/13
Originally posted by kadepsyson
Yeah its about money. Without this "money" you speak of this game woulnd't be made.
Novice Member
Joined: 1/16/13
Originally posted by kadepsyson
Then the whole concept is Kickstarter is not for you. Ignore the Kickstarter and if the game looks good when it launches buy it then. Simple concept.
Apprentice Member
Joined: 3/15/13
Thanks for the support :)
I agree with that post, the fact is making a game isn't that simple than you can afford not to sell it. That's why developpers and the game itself are so dependent on the publisher will, and why this game have a KS campaign to get free of it.
Novice Member
Joined: 10/22/10
So in this thread we basically have people pissing and moaning about how others choose to spend their money.
Advanced Member
Joined: 3/03/06
Originally posted by outd00rminer
No, swing and a miss, but thanks for playing.
People are concerned becuase some see it as a pay-to-test and are concerned that they will not use the best testers available, but those who pay the most for the privaledge instead.
No reason why some of those who pay will not be good testers, but not all will.
Truth is no-one but a handful of the dev team will see anything for a long time, alpha may not mean early alpha, it might mean final alpha renamed and broken down into bite-sized stages for those who want to pay for it. We simply don't know enough about the specifics of it yet.
Expresso gave me a Hearthstone beta key.....I'm so happy :)
Originally posted by Zinzan
But if that was their only concern they would have done a little digging instead of crying and saw that Mark has stated it won't simply be backers from the high paying tiers that will be in the alpha and beta. I think there is something to what you say but I think there's a concern from some corners that people will now have to pay to be in a beta instead of getting an early look at the game for free and deciding whether they like it or not, and that CU is helping establish such a precedent. But I'm pretty cynical when it come's to gamers in general so I could be wrong!
Well considering a lot of people now just play betas and don't actually ever buy the games, it makes sense for them to get their moneys worth out of you before you jump ship. How many times do we see posts about people pre-ordering to get into the open beta only to immediately cancel it just prior to the game being released. Games aren't made for free... someone has to pay the bills.
Novice Member
Joined: 3/17/13
If you don't trust MJ, CSE, KS or CU don't back it. But stop persuading others to follow a blurred vision of what's wrong with this project.
As said before: MJ will invite people to the IT if he feels they can contribute.
The people that have faith in the project should back it if they wish to do so... The people that don't have faith in it should not back the project and find other avenues of opportunity.
Methos, Armsman, EU Excalibur
Apprentice Member
Joined: 1/24/04
Hell is other people. - Sartre
It's just money...the only reason people are whining about backers getting to play in beta is jealousy for their inability to back in those tiers.
Again...it's just money. Sorry you're not in the bracket that can say that, don't worry you will be someday, maybe.
Beyond that, you can't fault them for having a tiered system that ACTUALLY GETS THE GAME FUNDED because people actually want to invest in the tiers.
I truly can't believe this tantrum is being thrown over such a miniscule amount of money. This is less than a single days work.
Elite Member
Joined: 6/06/12
We live in a fantasy world, a world of illusion. The great task in life is to find reality.
Originally posted by kadepsyson
Call it companies being smarter and more innovative. I assure you even the old MMO's if the ycould go back would of done the same thing. The reason they didn't is because they couldn't. Now that they can, they will. Its called capitilism.
Elite Member
Joined: 1/06/05
Originally posted by Zinzan
But you can never be assured that people are going to test even if it's by lottery.
However, people who invest, in any company, are many times given perks. Please keep in mind that this is not mutual fund investing, it's actually buying stock in a company.
Shareholder perks are common.
And one coveted activty for gamers is to be involved in an "actual beta".
If they invest then they shoudl get access over everyone else. From what I understand, this won't be the case for this game but an investor is an investor.
What's happening here is that people want everything to be equal and life doesn't work that way. Believe it or not, some companies have employee only stores where there are large discounts and investors can have access to it. Or some investment companies offer huge discounts at luxury stores.
Originally posted by pmiles
I couldn't agree more. That is why I love KSer being an option for small developers and niche gamers can be treated again. That is also why I have no problem with the backers who contribute more to these projects being given extra perks for their support.
Novice Member
Joined: 9/25/12
Originally posted by kadepsyson
Because there's no way of verifying that everyone who once played DAoC is interested in testing internal unfinished aspects of the game? Duh?
Novice Member
Joined: 3/25/06
Originally posted by Cirin
I get to name my own potion/poison, and I made this here thread.
Joined: 7/01/08
Sometimes absurdity is the best route back to reality.
I have been sitting on this forum and interacting with it more than playing any of the "MMORPGs" that I can play right now. That is sad, and it is exactly why I threw in some cash. I'd rather ride along with CU and feel like I have an opinion, a lobby, than play the garbage we have right now.
Is it a gamble? Yes. It is faith and hope? Yes and yes. Does it say more about the state of the industry than the state of the players? Yes.
Elite Member
Joined: 3/22/09
When will people start understanding that these are pledges and not investments.
It is exactly the same as pledging money to PBS stations ... so you can enjoy programming for shows you personally put money toward. It is a vote and as everyone has been reminded (at least in America), money is free speech.
You get a WHACK of rewards for you pledge and even the oportunity to impact the games development through early testing. Often even real investors do not have this voice. What possible way could a fan of a game have more impact on the game other than being hired by the company?
I also laugh each and every time when someone replies with the over used "a fool and his money ..." proverb. I have no idea why so many are scared or upset over how other people spend their money. How many PBS stations would exist without their viewers pledges? This game will not exist without it's fans. It is democratic. What confuses people is that they think it is capitalism. Democracy and capitalism are not mutually inclusive. Even America is a poor example of democracy now (it's far more a plutocracy) which is maybe what confuses people.
Pledging your money is a vote that you want this game made ... and you get some nice thank you gifts. You are not an investor. The capitalist engine then takes over and the game is made. We are not part of that (as official venture capistalist/investors other than influencing through testing feedback) until a product for consumption is made (release).
What is the alternative? CSE looks for major investors and distributor who likely takes over development control and player influence during development is minimal. The game is shaped into a genre that "fits" into the larger companies marketing model and we get a game nowhere near it's original concept. The only benefit is that it may have a larger budget but likely also a vastly inefficient method of development as often they dramatically alter development direction, timeline and even demographics mid-stream depending on how investor and quarterly reports go. They can also cancel a game even after spending more money than most indie games have because they look at the short term gain and not the long term. Game development has fallen into the plutocracy model and kickstarter is actually swinging it back into a the realm of democracy.
How in God's name is this the better than direct player/developer interaction with the game being the only element on the table? Perhaps if players are confused or upset over this evolution of game development. If so they still have options to confront developers and sell themselves as investors. I bet they wouldn't turn you down if you negotiated a proper deal. Good luck though trying to be one with even the largest pledges you can make on Kickstarter. A fool and his money may very well be soon parted ... but the only fools I see here are the ones assuming donations come from fools. They are consumers and fans making an educated decision that could lead to a product they enjoy and the development of long term jobs. These people vote with their money while others with their cynicism.
You stay sassy!
Originally posted by Tamanous
Wow, can we just take this one post and sticky it? This person couldn't have spoken words more true. I salute you!
Novice Member
Joined: 9/25/12
Originally posted by osiriszoran
Darkfall turned out to be not only epic, but one of the most impressive MMOs of the last 7 years.
Apprentice Member
Joined: 10/01/04
Originally posted by Hokibukisa
PEople want to fund this game because we want it to be made. We do not want it to be diluted by a publisher such as EA. We want to have the game that Mark has described in his interviews. We want a game that is not full of bullcrap to please the masses.
We want OUR game.
If you don't like it, go back to WoW son. But you're going to be missing the best PvP game concept that has EVER been thought up. I'd suggest you kick in for the kickstarter.


text:
Loading Joobili ...
Night of the Radishes
From: 2015.12.23 To: 2015.12.23
Official website:
This curious radish sculpturing event is one of Oaxaca's most popular Christmas events. No one really knows how the festival began but the event is considered to be over 100 years old. Competition is now fierce for the beautifully sculptured radishes. Local artists and townspeople pull their radishes out of the ground three days before the event and begin to carve their colourful creations for the special night. Displays often tell a story, such as Mexico's War of Independence or the story of Jesus, and include little houses, gardens and even villages. The festival also hosts a market, delicious local foods to try, children's workshops and of course, fireworks. And if you'd like one of the radish creations in your house, many of them are also for sale. With Christmas festivities continuing over the following days, it may be worth staying on.
Main album


text:
Forget password?
Remember Me
Go Play Live Music!
looking around the web, i noticed someone needs to write a nifty article, like one on eHow, entitled: "How to Start a Jam Band". if anyone wants to attempt this artlicle (i think it should be funny) post it as a response to this post!
1. smoke weed
2. noodle for 55 minutes straight in your basement/garage with friends
3. ???
4. profit
-love what you do, and respect everyone else
-no big heads in band that "have a vision" and its their way or now way
-practice practice more practice
-definitely smoke pot, or trip if your into synth, :-)
learn a basic I IV V progression and some pentatonic scales and thats it.
find people who play music just to play
not people who want to be in a band and get rich/famous
don't limit yourself to any style, play EVERYTHING and ANYTHING
when you think your song is done, add a couple solos
jam bands are lame... band thats jam are way better
if you want a really good band that jams learn to listen to everyone else in the band.
Listen and tour
there is already a new tool to find local musicians, its called Emuzikos. It's really easy to find musicians or bands you need without spending hours on forums.
Have a look at http://emuzikos.com
Improvise and try not to let people
call you a jam band and bag you...
By using the forums you agree to comply with our Terms of Use


text:
K2 products can only be shipped within the U.S.
(based on 7 reviews)
Ratings Distribution
5 Stars
4 Stars
3 Stars
2 Stars
1 Stars
of respondents would recommend this to a friend.
Best Uses
Reviewed by 7 customers
Sort by
Displaying reviews 1-7
Back to top
(1 of 1 customers found this review helpful)
Suprisingly versatile powder skis
By Susie
from Seattle, WA
About Me Expert
Comments about K2 MissDirected Skis - Women's 2013:
Incredible ski! Easily floats in powder and cuts through crud as expected with 117mm underfoot. Camber allows for suprisingly decent grip on hard pack- took these to the resort on an icy day to experiment and was impressed by their carving ability. Only place they faltered was moguls but all in all an incredible ski that is best served in the backcountry and can still be used at the resort.
Bottom Line Yes, I would recommend this to a friend
Was this review helpful? Yes / No
- You may also flag this review
(1 of 2 customers found this review helpful)
K2 MissDirected 169cm
By Rachel
from Mission Ridge, WA
This ski would be ideal for a lightweight girl looking to ski a lot of luxury powder! Personally I found the ski a little too soft for my taste, but I could see it being a great, maneuverable ski when the snow is deep enough. Because of the soft flex and small amount of effective edge, the ski is very pivoty and somewhat wobbly at high speeds, despite the wider waist. I wish they made the ski in a 179cm for women, as I think the 169cm is a tad too short for someone of substantial weight, height and ability.
By Chrissy
from Leadville CO
These are super fun and easy to ski . good in all terrain.
Great powder ski!
By Tbirdspence
from Breckenridge, CO
About Me Intermediate
These skis are the width of a snowboard when put together! They made my powder day 10x more enjoyable as it plows through anything. We just got 36" of snow and they handled like a champ. They're a bit heavy, but I'm also 110lbs. The one thing I was not happy with is the K2 graphic on the bottom of the ski. One is lifted a bit from manufacturing and it is not flesh with the rest of the bottom. Luckily the camber keeps this part off the snow, not affecting me. But still, c'mon k2!
(0 of 2 customers found this review helpful)
Looking forward to trying them out!
By lole
from seattle
I'm gearing up for a cat trip in BC. My sister has these skiis and told me they are a total blast, so, I tracked down a pair in the closeout section and bought them! I'm looking forward to trying them out!
Awesome skis!
By Kelsey
from Breckenridge, Co
Fun in powder, handles well on groomers, but not so great for trees. They love carving up the pow, and when it gets chundery they keep you from getting too chattery.
Skiin' the Deeeeeeep
By Dallas
from Stevens Pass
Awesome pow ski. Front rocker gives enough float to ski aggressively through deep powder without needing to keep too backseat. Camber underfoot keeps you a bit grounded out of the pow, which I liked.


text:
Our long history of success rests on a foundation of concern and generosity from many people throughout the community. You can help ensure the future of The Bird Rescue Center's rehabilitation and educational programs. We welcome your support. There are many direct and indirect ways you can participate
Wish List
Gift Shop / BRC Merchandise


text:
35 Free Android Apps for Business
By Pam Baker | Article Published July 22, 2014
Free Android apps for time management, communication, accounting, and other key business functions.
Tags: Android, android apps, apps, app store, mobile apps, enterprise app
The IT App Store: IT's Latest Weapon Against Amazon
By Rob Enderle | Article Published August 09, 2013
BMC's AppZone can help IT stay relevant in a world defined by BYOD and cloud services.
Tags: cloud computing, Amazon Web Services, app store, BMC, BYOD, AppZone
Google Play Downloads Surpass App Store Downloads in Q2
By Cynthia Harvey | Article Published July 31, 2013
However, Apple's platform still generates more revenue.
Tags: Apple, app store, mobile apps, downloads, tablets, revenue, Google Play
Are Most iOS Apps 'Zombies'?
By Cynthia Harvey | Article Published July 10, 2013
A new survey claims that two-thirds of the apps in the App Store get almost no downloads.
Tags: apps, app store, IOS
Apple Drops App Store Trademark Lawsuit
By Cynthia Harvey | Article Published July 10, 2013
Amazon can continue to use the name "Appstore."
Tags: Apple, lawsuit, app store, trademark, Amazon Appstore
Business Intelligence Comes to Office 365
By Cynthia Harvey | Article Published July 09, 2013
In addition, the Office and Sharepoint Stores are expanding to more markets.
Tags: cloud computing, Microsoft, business intelligence, SharePoint, app store, Office 365
Office Comes to the iPhone
By Cynthia Harvey | Article Published June 14, 2013
To use it, you'll need an Office 365 subscription.
Tags: Microsoft Office, app store, Word, PowerPoint, Excel, IOS, Office 365, Apple iPhone, Office productivity
Ubuntu vs. Windows 8: Which Is Better Overall?
By Matt Hartley | Article Published May 20, 2013
It's much easier to find a system with Windows 8 pre-installed, but Ubuntu offers a better interface and better apps.
Tags: open source, operating system, Cloud, Microsoft, Ubuntu, apps, Windows 8, Office, app store, OS, interface
How to Understand the Rise of Google
By Mike Elgan | Article Published May 15, 2013
Google I/O starts today. Here's why Google's developer conference is technology's Main Event.
Tags: Google, Android, iPhone, iPad, Apple, Gmail, app store, Siri, google+, Google Play, products and services, Google Now
App Store Approaching 50 Billion Downloads
By Cynthia Harvey | Article Published May 03, 2013
One lucky Apple customer will get a $10,000 iTunes gift card.
Tags: iPhone, iPad, Apple, iTunes, app store, download
Apple, Amazon Ordered to Hold Settlement Talks in Trademark Dispute
By Cynthia Harvey | Article Published January 16, 2013
The lawsuit centers on the use of the name "app store."
Tags: Amazon, Apple, lawsuit, app store, trademark, settlement, appstore
Google Play Offers Private Channels for Enterprises
By Cynthia Harvey | Article Published December 06, 2012
Companies can now set up private Android app stores for use by their employees.
Tags: app store, Enterprise, Google Play
Top 50 iPhone 5 Apps
By Don Reisinger | Article Published November 03, 2012
Apple's iPhone 5 might be new, but there are already a host of really great new apps for the smartphone.
Tags: Apple, apps, app store, iPhone 5
First Apple App Store Malware Found by Kaspersky
By Datamation.com Staff | Article Published July 06, 2012
The Find and Call app stole contact data and uploaded it to a remote server.
Tags: security, Apple, malware, app store, trojan
Apple App Store Downloads Top 25B
By Datamation.com Staff | Article Published March 05, 2012
A customer in China received $10,000 for making the lucky 25 billionth download.
Tags: Apple, app store
Windows Phone Marketplace Passes 50,000 Apps
By Datamation.com Staff | Article Published December 28, 2011
The app store's pace of growth is increasing rapidly.
Tags: Windows Phone, app store
Microsoft to Launch Windows 8 Beta, Windows Store in February
By Thor Olavsrud | Article Published December 07, 2011
The software giant will open its latest operating system for public beta in late February, and it will open its new Windows Store for Metro-style apps at the same time.
Tags: SDK, developers, Windows 8, app store, windows store
Microsoft Pitches Windows Store for Apps
By Datamation.com Staff | Article Published December 07, 2011
Microsoft promises developers "a bigger bite of the Apple."
Tags: Windows, app store
The App Store Goes Corporate: Smartphone as Business Tool
By Stuart J. Johnston | Article Published October 06, 2011
With the smartphone now a leading tool of enterprise productivity, the business-focused app store is on the rise.
Tags: smartphone, Enterprise IT, app store
Apple Users Buying 61% More Apps, Paying 14% More Per App
By Datamation.com Staff | Article Published July 11, 2011
An analyst says that the average iOS device owner will download 83 apps this year.
Tags: app store
Linux Moves Toward Apple App Store
By Paul Rubens | Article Published February 02, 2011
Linux developers imitate Apple in an attempt to improve the Linux user experience.
Tags: Linux, Apple, Linux downloads, download apps, app store
Apple Reveals All Time Most Popular Downloads
By David Needle | Article Published January 19, 2011
There's plenty of fun among the most downloaded apps for the iPhone and iPad and also some surprises.
Tags: iphone apps, iPad apps, Apple, app store, downloads
Apple Details Mac App Store Release - It's Soon!
By David Needle | Article Published December 16, 2010
Will the success of the mobile app store model carryover to the desktop?
Tags: iphone apps, iPad apps, Mac, steve jobs, app store
Apple Now Taking Devs' iPad App Store Submissions
By Andy Patrizio | Article Published March 20, 2010
Developers have been notified that if they want to have their app ready for launch day, they have to keep to a short deadline. How much time do they have?
Tags: developers, iPad, Apple, Apple iPad, app store
Does an iPad Shortage Loom?
By Andy Patrizio | Article Published March 01, 2010
Analyst notes troubles with one of Apple's manufacturing partners may mean a limited supply or even a possible delay in availability of the new iPad.
Tags: iPhone, iphone apps, iPad, Apple, app store
Is Apple Testing Tablet? Flurry Says Yes
By Andy Patrizio | Article Published January 25, 2010
A mobile analytics firm finds what it claims is evidence that Apple tablet prototypes are being tested.
Tags: iPhone, Apple, tablet, app store, iSlate
eBay Reveals App Store Details
By David Needle | Article Published April 05, 2009
eBay has ambitious plans for an app store, which will be a venue for developers in the expanding mobile market.
Tags: developer, iPhone, privacy, eBay, app store
So What Exactly Is In BlackBerry App World?
By Chris Nerney | Article Published April 02, 2009
So What Exactly Is In BlackBerry App World?
Tags: mobile, Blackberry, iPhone, Apple, app store, RIM, App World
Is the Apple App Store Reviewing System Defective by Design?
By Adrian Kingsley-Hughes | Article Published August 12, 2008
Many reviewers believe that the App Store should be entirely freeware, and that developers who have put time and effort into an application should give it away for nothing.
Tags: developer, iPhone, IT, Apple, app store
81 Tasty iPhone Apps
By Cynthia Harvey | Article Published July 28, 2008
Get tickets, play games, count calories, find your location, create play lists, track sports scores, and more. Your iPhone still cant boil an egg, but with these apps it can do most everything else.
Tags: search, software, iPhone, Apple, app store
iPhone 3G Review: Top Apps, Gripes, and Gadget Love
By Joe Kissell | Article Published July 18, 2008
It's far from technically perfect, but its pretty darn cool. Plus: some must-have Apps from the iPhone App Store.
Tags: email, iPhone, smartphones, app store, iphone 3G


text:
Lioneye's Glare
Imperial BowBow
Physical Damage: (62–245 to 85–302)
Critical Strike Chance: 5%
Attacks per Second: (1.59 to 1.74)Requires Level 66, 212 Dex(6 to 12)% increased Elemental Damage with Weapons(150 to 175)% increased Physical Damage
Adds (6–12 to 20–32) Physical Damage
(10 to 20)% increased Attack Speed
+(80 to 100) to maximum Mana
Hits can't be Evaded"See without doubt, slay without hesitation."
- Marceus Lioneye of Sarn
Lioneye's Glare is a unique Imperial BowImperial BowBow
Physical Damage: 19–78
Critical Strike Chance: 5%
Attacks per Second: 1.45Requires Level 66, 212 Dex(6 to 12)% increased Elemental Damage with Weapons.
This item has the hits can't be evaded modifier.
Drop restrictions
Lioneye's Glare is a Map-only unique item that requires an item level of 71 to spawn (via drop) and can be generated via Orb of ChanceOrb of ChanceStack Size: 20Upgrades a normal item to a random rarityRight click this item then left click a normal item to apply it.
Shift click to unstack. with a lower item level (note that using a chance orb on an imperial bow can also result in spawning a WindripperWindripper
Imperial BowBow
Physical Damage: 19–78
Elemental Damage: (32–48 to 40–60), (1–80 to 1–100)
Critical Strike Chance: (8 to 9)%
Attacks per Second: (1.59 to 1.67)Requires Level 66, 212 Dex(6 to 12)% increased Elemental Damage with WeaponsAdds (32–48 to 40–60) Cold Damage
Adds (1–80 to 1–100) Lightning Damage
(10 to 15)% increased Attack Speed
(60 to 80)% increased Critical Strike Chance
15% increased Quantity of Items Dropped by Slain Frozen enemies
30% increased Rarity of Items Dropped by Slain Shocked enemiesIt hunts; as silent as falling snow, as deadly as the tempest. unique).[1]
Version history
See also
- Lioneye's PawsLioneye's Paws
Bronzescale BootsArmour: 48
Evasion: 48
Requires Level 30, 30 Str, 30 Dex+(40 to 60) to Strength
+(40 to 60) to Dexterity
Adds 12–24 Fire Damage
20% Increased Movement Speed
40% Reduced Movement Speed when on Low Life
20% Increased Block and Stun Recovery
Cannot be stunned when on Low LifeStand and lead the righteous pride,
Fight till death, never hide.
- Lioneye's RemorseLioneye's Remorse
Pinnacle Tower ShieldChance to Block: 30%
Armour: (1218 to 1421)
Requires Level 70, 159 Str(200 to 250)% increased Armour
+(80 to 100) to maximum Life
5% reduced Movement Speed
20% increased Block and Stun Recovery
−25 Physical Damage taken from Projectile Attacks
5% additional Block ChanceMarceus' unblemished shield is a testament to his arrogance... and his fate.
- ↑ Chris (November 5, 2013). "1.0.0f Patch and Data about League Distributions and Map-only Uniques". Official Path of Exile Forums. Retrieved March 13, 2014.


text:
Tuesday, February 19, 2013
Coastal Fertility Specialists in conjunction with the Department of Obstetrics and Gynecology at the Medical University of South Carolina are conducting a groundbreaking study on the impact common environmental contaminants have on the female reproductive system.
Coastal Fertility Specialists' physicians are partnering with MUSC and NIST researchers at the Hollings Marine Laboratory to examine how common, everyday contaminants from household products such as plastic water bottles, makeup, hairspray, deodorant and other environmental exposures negatively affect female egg quality and quantity. It is the doctors' belief, based on preliminary human research, and more definitive research performed on animals in the wild, that these contaminants can cause irreversible damage to a woman's reproductive system.
In fact, award-winning MUSC researcher, Dr. Louis Guillette has conducted compelling studies on the impact of toxic chemicals on the reproductive systems of alligators and other wildlife. His findings show that environmental toxins are responsible for reproductive abnormalities in wildlife living in the waters of Lake Apopka in Florida, where the majority of his research has taken place.
Decreased egg number and decreased egg quality are common causes of infertility and based on some studies may be increasing in incidence. Co-founders of Coastal Fertility Specialists, Dr. Michael Slowey and Dr. John Schnorr are teaming with Dr. Guillette to help expand the scope and breadth of this important reproductive research. Dr. Guillette's research raised red flags about what potential impacts chemicals may also have on human reproductive health, especially as other researchers have shown that sperm counts have dropped and testicular cancer is on the rise. Guillette's studies demonstrate that there is a direct link between environmental chemicals and male and female reproductive health.
For this reason, the physicians at Coastal Fertility Specialists are asking for patient volunteers currently undergoing In Vitro Fertilization (IVF) treatment. The doctors will take samples of the patient's blood as well as the fluid around the eggs to test for a variety of environmental toxins including Bisphenol A (BPA) and phthalates. The researchers at MUSC and NIST will then analyze the samples to find out if toxic materials are contained in the fluids.
"There is no doubt that BPA, phthalates and other common environmental contaminants stimulate our hormonal system and impact all of us. Our knowledge in this area is in its infancy and studies such as this have the ability to dramatically improve reproductive health throughout the world. Imagine if we could measure your blood and say, stop drinking out of plastic and stop using hairspray and your reproduction will improve," says Dr. John Schnorr, reproductive endocrinologist at Coastal Fertility
For more information on the environmental study please contact Holly Clayson at
firstname.lastname@example.com or 843-412-4894.
Moultrie News is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. We do not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not Moultrie News.
If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website. Read our full terms and conditions.
© 2015 Moultrie News an Evening Post Industries company. All Rights Reserved.
Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Parental Consent Form.


text:
Thursday, February 27, 2014
Goose Creek city officials have all the approvals they need to go ahead with a loan that will pay for two new fire stations.
City officials are expected to close the deal on March 4.
At a special Goose Creek City Council meeting on Feb. 18 council voted to approve the second reading of an ordinance to borrow $7.5 million to purchase two new fire stations.
This was based on City Administrator Dennis Harmons recommendation.
The numbers are very good, Harmon said. The financial corporation makes the bid. The corporation is the holding company.
The city received three bids from three banks earlier that day.
Councilmember Jerry Tekac abstained from the discussion and voting on which bank to choose because he is employed by NBSC, one of the bidders. Harmon said Tekac did the proper thing.
BB&Ts bid was the lowest with an interest rate of 2.88 percent and a 15-year term, Harmon said.
Suntrust offered a 2.92 percent interest rate and payments at anytime with adjustments.
NBSC offered a 3.5 percent interest rate with 10-year financing, Harmon said.
Harmons recommendation was BB&T. After a vote by five of the six councilmembers and Mayor Michael Heitzler, the bid was awarded to BB&T.
They will buy the bonds, Harmon said. We anticipate BB&T will hold the bond to term.
This is a momentous occasion that were building a new fire station headquarters and substation. Its a 14-month construction period. We hope to be up and running with that facility by mid-2015, no later than third quarter 2015.
Citizen Dennis Wenger asked if the price includes fire engines and manpower.
The short answer to his question was no.
The headquarters and training center is on property the city owns, Harmon said. The substation is on Old Mt. Holly Road. We need one pumper (truck). We will have it at that time. This contract does not include furnishing or personnel.
Its been a long time coming as far as the fire department is concerned. These will be first-class facilities.
The Gazette is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. We do not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not The Gazette.
If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website. Read our full terms and conditions.
© 2015 The Gazette an Evening Post Industries company. All Rights Reserved.
Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Parental Consent Form.


text:
Eccentric levels of beauty and power.
With over 30 years of engineering and metallurgy skills, Eccentric Systems starts with only premium quality brass and steel alloy in the production of our snare drum lines. When quality of sound is the most important factor, consistency of shell thickness, sharp tight bends and meticulous detail finishing are crucial.
This 14 x 6-1/2" Bright Brass Snare drum features a standard 1mm brass shell that emits a dry, full tone with controlled brightness and an aggressive attack. This snare is crowned with 2.3mm Flatheadz hoops and a 10-lug configuration. The crack of this snare is honed and aided by a high-end strainer and a German snare wire.


text:
The free trips of Solomon Ortiz: Convicted pair paid for some
Congressman was unaware of their crimes, his aide says
Ortiz spokeswoman Cathy Travis couldn't reach him Monday, but said she is sure he was unaware of the crimes committed by Kenneth and Ping Lee Cohen, of Houston. The Cohens pleaded guilty in February to conspiracy to defraud the U.S. government and are awaiting sentencing.
These trips are among the 46 paid by organizations for Ortiz and his staff between 2000 and August 2005, according to a Caller-Times analysis of data made available by the Center for Public Integrity.
The nonprofit research organization spent a year compiling and analyzing nearly $50 million worth of travel by members of Congress, their families and staffs paid for by private companies or organizations. Ortiz ranked fourth out of 46 Texas members in travel expenses.
Ortiz's travels paid for by the Cohens coincided with the years in which, according to federal authorities, they made contact with Chinese nationals, helped them obtain fraudulent visas and forged documents showing supposed relationships between U.S. and Chinese companies, which were used in petitions for the Chinese residents to stay in the United States as executive-level employees. An indictment listed nearly $120,000 in payments to the couple for their work.
"I am certain that he didn't know anything about that," Travis said. "When he finds out on his Blackberry he will be very surprised."
Asia Access Corporation, a company listed under Kenneth Cohen's name, paid for Ortiz and his former chief of staff, Florencio Rendon, to visit China four times in those five years, according to a Caller-Times analysis of congressional travel data. Ping Lee Cohen listed her association with Asia Access in a $1,000 political donation to Ortiz in 2000.
Lawyers for the couple either did not return calls or declined to comment.
Ortiz took 12 trips to China between 2000 and 2005. He also traveled to Mexico, Puerto Rico and the Dominican Republic.
Travis said she didn't know the reason for the trips with Asia Access. But many of the other Asian trips, often listed as "fact finding" in travel disclosure forms, benefited his South Texas district, she said. Ortiz has helped bring at least two Asian companies to the area: AMFELS Inc., which she said brought nearly 2,500 jobs to the Port of Brownsville, and a shrimping company. Travis said she didn't know the name of the company or how many jobs it created.
Ortiz also tried to lure a Singapore company to the Corpus Christi International Airport, but that deal fell through. That company paid for two trips to Asia by him and his staff.
Ortiz has helped the two ports in his district, in Brownsville and Corpus Christi, form business agreements with Asian ports, Travis said, and helps business owners here make contacts in Asia.
This was the case with Corpus Christi-based Integrity Communications, which twice paid for Ortiz and Rendon to visit Hong Kong and Beijing, according to travel disclosure forms.
Travis said the company focuses on telecommunications infrastructure. Company president Bill Sugarek did not return calls for comment Monday.
Travis said she didn't know what the Cohens' interest was in China, but said they were on friendly terms with the congressman.
"I don't know when and how he met Ken and Ping," she said. "I know he has known them for a very long time."
Employees or owners with both Integrity Communications and Asia Access have donated to Ortiz's political campaign funds. The Cohens collectively gave $6,000 between 1997 and 2003. Sugarek gave $2,000 in 2005.
The Center for Public Integrity has not yet released information that would show how Ortiz ranks among all representatives and senators, but he was not listed as one of the top 10 travelers.
Congressional travel documents are only available in paper form in Cannon House Office Building in Washington, D.C., making analysis of overall spending difficult until the nonprofit group compiled the information in an electronic format.
Ortiz faced some criticism for his travel last year. Corpus Christi lawyer Filemon Vela paid $11,100 for the congressmen to fly to China months after Ortiz got legislation passed naming a new Brownsville courthouse after Vela's father, a former judge, and Judge Reynaldo Garza.
Ortiz called the timing a coincidence. He had been pushing for years to get the courthouse named after Vela.
Officials with the U.S. Attorney's office, which prosecuted the Cohens, would not comment on the case. The Cohens will be sentenced in August and face up to five years in prison and $250,000 fines.
Contact Sarah Viren at 886-4316 or HYPERLINK mailto:firstname.lastname@example.com firstname.lastname@example.com
Subscribe to the Caller-Times
Need Help? Call us at 1-800-566-8098.
Monday-Friday: 6am-3pm / Saturday: 7am-11am / Sunday: 7am-11am